What are the key differences between M1 (classically activated) and M2 (alternatively activated) macrophages?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 19, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

M1 vs M2 Macrophages: Key Functional and Metabolic Differences

M1 macrophages are classically activated, pro-inflammatory cells that rely on glycolysis and produce reactive oxygen species (ROS) and pro-inflammatory cytokines to eliminate pathogens, while M2 macrophages are alternatively activated, anti-inflammatory cells that depend on oxidative phosphorylation and promote tissue repair, phagocytosis of debris, and resolution of inflammation. 1

M1 Macrophages (Classically Activated)

Activation Triggers

  • Induced by LPS, TNF-α, and IFN-γ exposure, which drives their differentiation from infiltrating monocytes recruited by MCP-1 and GM-CSF 1
  • Innate lymphoid cells contribute to M1 differentiation during the acute inflammatory phase 1

Metabolic Profile

  • Predominantly utilize aerobic glycolysis rather than oxidative phosphorylation, representing a fundamental metabolic switch upon activation 1, 2
  • Display two breaks in the TCA cycle that result in accumulation of itaconate (a microbicidal compound) and succinate 2
  • Excess succinate stabilizes HIF-1α, which activates transcription of glycolytic genes and sustains the glycolytic phenotype 2

Functional Characteristics

  • Produce high levels of ROS, nitric oxide (NO), and hydrolytic enzymes required for effectively eradicating invading pathogens 1
  • Secrete pro-inflammatory cytokines including TNF-α, IL-1α, IL-1β, IL-6, IL-8, and IL-12 1, 3, 2
  • Induce polarization of T cells into the Th1 phenotype, establishing long-term inflammatory responses that include adaptive immunity 1, 3
  • Central role in host defense against infection and initiating inflammatory responses 4

Clinical Context

  • In acute pulmonary embolism, M1 macrophages infiltrate the RV outflow tract within 18 hours 1
  • Protumorigenic in certain contexts, as M1 polarization can be regulated by T lymphocytes in the tumor microenvironment 1

M2 Macrophages (Alternatively Activated)

Activation Triggers

  • Induced by anti-inflammatory mediators TGF-β and IL-10, along with IL-4 and IL-13 1, 3, 5
  • Predominate 6 weeks after acute right ventricular pressure overload, contributing to repair processes 1

Metabolic Profile

  • Primarily dependent on oxidative phosphorylation (OXPHOS) with an intact TCA cycle 1, 2
  • The TCA cycle provides substrates for the electron transport chain complexes, supporting their energy requirements 2
  • Characterized by specific pathways regulating lipid and amino acid metabolism that support their anti-inflammatory functions 2

Functional Characteristics

  • Display upregulated phagocytic capacity aimed at clearing tissue from cellular debris left from prior neutrophilic attack 1
  • Produce anti-inflammatory cytokines, particularly IL-10, which regulates negative feedback on pro-inflammatory macrophage activity 3, 5
  • Contribute to tissue maturation through reorganization of extracellular matrix and vasculature during the remodeling phase, a process that can take up to years 1
  • Promote resolution of inflammation, phagocytose apoptotic cells, drive collagen deposition, and coordinate tissue integrity 2
  • Release anti-inflammatory mediators and neurotrophic factors including growth factors that support tissue repair 2

Clinical Context

  • In chronic right ventricular pressure overload, secretory M2 macrophages predominate and contribute to repair 1
  • In metabolic dysfunction-associated steatotic liver disease, M2 macrophages contribute to increased GDF15 levels as a stress-induced compensatory mechanism 1

Critical Distinctions for Clinical Practice

Temporal Dynamics

  • M1 macrophages dominate early inflammatory phases (within hours to days), while M2 macrophages emerge during resolution phases (weeks to months) 1, 5
  • The switch from M1 to M2 is promoted by downregulation of inflammatory mediators and upregulation of TGF-β and IL-10 1, 5

Metabolic Switching as a Therapeutic Target

  • The metabolic phenotype directly supports functional polarization: glycolysis enables rapid inflammatory responses in M1, while OXPHOS supports sustained phagocytic and repair functions in M2 2
  • Modulating macrophage polarization by targeting metabolic pathways holds promise for treating inflammatory diseases 6, 4

Common Pitfalls

  • M1 and M2 represent extremes of a continuum, not discrete populations; macrophages exist along a spectrum of activation states in vivo 7, 4
  • Context matters: in tumors, M2 macrophages can be protumorigenic, while M1 can be antitumor, though T lymphocyte interactions regulate this balance 1
  • Persistent M1 inflammation without transition to M2 leads to chronic tissue damage, while premature M2 activation may allow pathogen persistence 1, 5

Starvation Effects

  • Acute starvation increases M1 macrophage effector function in certain infections (e.g., Listeria monocytogenes), decreasing bacterial load and mortality 1
  • M1 and dendritic cells switch to glycolysis upon activation, while M2 macrophages and T regulatory cells rely on fatty acid oxidation and OXPHOS, making M2 potentially more resilient during nutrient restriction 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

The Metabolic Signature of Macrophage Responses.

Frontiers in immunology, 2019

Guideline

Immune System Support Strategies

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Macrophage polarization in inflammatory diseases.

International journal of biological sciences, 2014

Guideline

Inflamação nos Tecidos

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Macrophage M1/M2 polarization.

European journal of pharmacology, 2020

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.